According to the 2021 WHO CNS classification guidelines, oligodendrogliomas are molecularly characterized by mutations in the isocitrate dehydrogenase (IDH) and the co-deletion of chromosome arms 1p and 19q [2,8]. Here, IDH1 is linked to oligodendroglioma.